EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

UBE2T‐Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation‐Mediated CAFs Activation and ECM Deposition in Pancreatic Cancer

Yong Ma iD, Wenbo Liu iD, Mingdou Li iD, Tao Wang, Bin Zhao, Keshen Wang, Qichen He, Haonan Sun, Huiguo Qing, Xiaoying Guan, Wengui Shi, Long Qin und 5 weitere

Advanced Science · 2026-04 · 13 (22)

DOI: 10.1002/advs.202514933 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 15.02.2026. Verfasst von Yong Ma und 16 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Tumor Suppressor Protein p53, Glycolysis, Extracellular Matrix. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Gansu Province Joint Scientific Research Fund, Gansu Provincial Health Industry Science and Technology Innovation Major Scientific Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although glycolysis is a metabolic hallmark of pancreatic ductal adenocarcinoma (PDAC), it remains unclear whether the excessive lactate produced regulates CAF lactylation to promote extracellular matrix (ECM) deposition. The multi‐omics and spontaneous model findings indicate that lactate accumulation in the tumor microenvironment (TME) promotes histone H3 lysine 18 lactylation (H3K18la) and activation of cancer‐associated fibroblasts (CAFs), leading to both ECM densification and impaired immunotherapy efficacy in PDAC. Mechanistically, ubiquitin‐conjugating enzyme E2T (UBE2T) acts as an initiating factor that promotes p53 positive feedback degradation through modulation of ribosome biogenesis, thereby enhancing lactate metabolic crosstalk via glycolytic reprogramming. Genetic ablation or pharmacological inhibition of UBE2T using the selective inhibitor pentagalloylglucose (PGG) disrupts lactate metabolic crosstalk, suppresses stromal deposition, and promotes intratumoral CD8 + T cells infiltration. Furthermore, the combination of PGG and anti‐PD‐1 therapy exhibits synergistic effects and survival benefits in spontaneous PDAC mice and immune‐reconstituted patient‐derived xenografts. Collectively, these findings reveal that UBE2T drives p53 positive feedback degradation to enhance glycolysis of PDAC, leading to excessive lactate production, which promotes H3K18la in CAFs and subsequent ECM deposition. Targeting UBE2T represents a potential strategy to improve the efficacy of immunotherapy in PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsTumor Suppressor Protein p53GlycolysisExtracellular MatrixCancer-Associated FibroblastsUbiquitin-Conjugating EnzymesCarcinoma, Pancreatic DuctalAnimalsHumansMiceTumor MicroenvironmentMetabolic ReprogrammingCell Line, Tumor

Stichwörter der Autor:innen

UBE2Timmunotherapylactylationpancreatic cancertumor microenvironment

Substanzen

Tumor Suppressor Protein p53Ubiquitin-Conjugating Enzymes

Autor:innen und Institutionen

  • The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
  • Department of General Surgery, Lanzhou University Second Hospital, Lanzhou, China.
  • Gansu Tumor Immunology Basic Disciplines Research Center, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China.
  • Department of Neurosurgery, Lanzhou University Second Hospital, Lanzhou, China.
  • Department of Pathology, Lanzhou University Second Hospital, Lanzhou, China.
  • Cuiying Biomedical Research Center, Lanzhou University Second Hospital, Lanzhou, China.

ORCID-Profile: Yong Ma, Wenbo Liu, Mingdou Li, Zeyuan Yu, Xiangyan Jiang, Zuoyi Jiao

Förderung

  • National Natural Science Foundation of China
  • Gansu Province Joint Scientific Research Fund
  • Gansu Provincial Health Industry Science and Technology Innovation Major Scientific Research Project
  • Gansu Province Traditional Chinese Medicine Science and Technology Tackling Key Projects
  • Lanzhou University Second Hospital

Zitieren

APA

Ma, Y., Liu, W., Li, M., Wang, T., Zhao, B., Wang, K., He, Q., Sun, H., Qing, H., Guan, X., Shi, W., Qin, L., Dong, Y., Zhou, H., Yu, Z., Jiang, X., & Jiao, Z. (2026). UBE2T‐Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation‐Mediated CAFs Activation and ECM Deposition in Pancreatic Cancer. Advanced Science, 13(22). https://doi.org/10.1002/advs.202514933

Vancouver

Ma Y, Liu W, Li M, Wang T, Zhao B, Wang K, et al. UBE2T‐Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation‐Mediated CAFs Activation and ECM Deposition in Pancreatic Cancer. Advanced Science. 2026;13(22). doi:10.1002/advs.202514933

BibTeX
@article{Ma2026,
  author = {Ma, Yong and Liu, Wenbo and Li, Mingdou and Wang, Tao and Zhao, Bin and Wang, Keshen and He, Qichen and Sun, Haonan and Qing, Huiguo and Guan, Xiaoying and Shi, Wengui and Qin, Long and Dong, Yuman and Zhou, Huinian and Yu, Zeyuan and Jiang, Xiangyan and Jiao, Zuoyi},
  title = {UBE2T‐Driven p53 Degradation Rewires Glycolysis to Orchestrate Lactylation‐Mediated CAFs Activation and ECM Deposition in Pancreatic Cancer},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {22},
  doi = {10.1002/advs.202514933}
}
Kostenlos starten →